Advertisement
Loading...

Shattuck Labs, Inc.

STTKNASDAQ
Healthcare
Biotechnology
$6.09
$-0.08(-1.30%)
U.S. Market opens in 4h 51m

Shattuck Labs, Inc. Fundamental Analysis

Shattuck Labs, Inc. (STTK) shows weak financial fundamentals with a PE ratio of -13.75, profit margin of -49.87%, and ROE of -60.73%. The company generates $0.0B in annual revenue with weak year-over-year growth of -82.52%.

Key Strengths

Cash Position13.23%
PEG Ratio-0.15
Current Ratio22.06

Areas of Concern

ROE-60.73%
Operating Margin-52.66%
We analyze STTK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3854.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3854.6/100

We analyze STTK's fundamental strength across five key dimensions:

Efficiency Score

Weak

STTK struggles to generate sufficient returns from assets.

ROA > 10%
-48.84%

Valuation Score

Excellent

STTK trades at attractive valuation levels.

PE < 25
-13.75
PEG Ratio < 2
-0.15

Growth Score

Moderate

STTK shows steady but slowing expansion.

Revenue Growth > 5%
-82.52%
EPS Growth > 10%
53.02%

Financial Health Score

Excellent

STTK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
22.06

Profitability Score

Weak

STTK struggles to sustain strong margins.

ROE > 15%
-6073.23%
Net Margin ≥ 15%
-49.87%
Positive Free Cash Flow
No

Key Financial Metrics

Is STTK Expensive or Cheap?

P/E Ratio

STTK trades at -13.75 times earnings. This suggests potential undervaluation.

-13.75

PEG Ratio

When adjusting for growth, STTK's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values Shattuck Labs, Inc. at 7.16 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.16

EV/EBITDA

Enterprise value stands at -7.97 times EBITDA. This is generally considered low.

-7.97

How Well Does STTK Make Money?

Net Profit Margin

For every $100 in sales, Shattuck Labs, Inc. keeps $-49.87 as profit after all expenses.

-49.87%

Operating Margin

Core operations generate -52.66 in profit for every $100 in revenue, before interest and taxes.

-52.66%

ROE

Management delivers $-60.73 in profit for every $100 of shareholder equity.

-60.73%

ROA

Shattuck Labs, Inc. generates $-48.84 in profit for every $100 in assets, demonstrating efficient asset deployment.

-48.84%

Following the Money - Real Cash Generation

Operating Cash Flow

Shattuck Labs, Inc. generates limited operating cash flow of $-17.62M, signaling weaker underlying cash strength.

$-17.62M

Free Cash Flow

Shattuck Labs, Inc. generates weak or negative free cash flow of $-17.62M, restricting financial flexibility.

$-17.62M

FCF Per Share

Each share generates $-0.37 in free cash annually.

$-0.37

FCF Yield

STTK converts -14.10% of its market value into free cash.

-14.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-13.75

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

292.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

22.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-0.49

vs 25 benchmark

ROCE

Return on capital employed

-0.54

vs 25 benchmark

How STTK Stacks Against Its Sector Peers

MetricSTTK ValueSector AveragePerformance
P/E Ratio-13.7529.05 Better (Cheaper)
ROE-60.73%746.00% Weak
Net Margin-4987.40%-49773.00% (disorted) Weak
Debt/Equity0.020.40 Strong (Low Leverage)
Current Ratio22.064.00 Strong Liquidity
ROA-48.84%-21585.00% (disorted) Weak

STTK outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Shattuck Labs, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-93.96%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

19.96%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

28.88%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ